Results of structural analysis of medical appointments of quercetin drugs and its derivatives in Ukraine




angiopathy, angioprotectors, quercetin, medical prescribing, frequency of medical prescriptions


The aim: to analyze the structure of medical prescriptions for quercetin and its derivatives in Ukraine

Materials and methods. We used data from an expert survey of doctors from 25 cities of Ukraine, which was conducted during 2017-2018. The survey involved doctors of various specialties who had «very high» (k ≥ 0.91), «high» (k = 0.71-0.90) and «satisfactory» (k = 0.51-0.70) level of competence. This indicator was determined using five coefficients (k1+n), which characterized the level of theoretical and applied training of specialists in the organization of the medical and diagnostic process for patients suffering from various types of angiopathies. We used the historical, analytical, comparative, systemic, logical, hypothetical-deductive, mathematical and statistical methods, as well as the expert survey method.

Results. It was found that the largest number of appointments (51.82%) was made by therapists/family doctors, and the smallest - by endocrinologists (3.6%). The vast majority of respondents (except for allergologists and endocrinologists) prescribed these drugs in treatment according to the main diagnosis of the patient. At the same time, only therapists/family doctors and cardiologists prescribed quercetin and its derivatives in a wide range of development of the clinical picture of the pathology, namely the main diagnosis, with its complications and associated diseases. Doctors of all specialties, except for otolaryngologists noted the use of quercetin and its derivatives in the treatment of concomitant pathologies of sick patients. The first position in the structure of medical appointments (1st level of ICD-10) was taken by appointments in the treatment of I-diseases of the circulatory system (78.97%), the second – by J-diseases of the respiratory system (11.30%), and the third – K-digestive system diseases (6.04%). In the structure of prescriptions for patients with cardiovascular pathologies, the largest share was made in the treatment of angina pectoris (49.60%), in the second position – chronic ischemic heart disease (21.61%), and in the third – other cerebrovascular diseases (10.60%).

Conclusions.  It was proved that the highest prescribing rates of quercetin and its derivatives were carried out by therapists/family doctors in the treatment of diseases of the cardiovascular system according to the main diagnosis, its complications and associated pathologies. The low level or lack of prescription of drugs of this group in doctors of other specialties requires further research in the indicated direction

Author Biographies

Serhii Bobokalo, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

Senior Laboratory Assistant

Department of Cosmetology and Aromatology

Lyudmila Almakaieva, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

Doctor of Pharmaceutical Sciences, Professor

Department of Cosmetology and Aromatology

Hanna Panfilova, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

Doctor of Pharmaceutical Sciences, Professor

Department of Organization and Economics of Pharmacy

Oksana Tsurikova, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

PhD, Assistant

Department Quality Management


  1. Del Bo', C., Bernardi, S., Marino, M., Porrini, M. et. al. (2019). Systematic Review on Polyphenol Intake and Health Outcomes: Is there Sufficient Evidence to Define a Health-Promoting Polyphenol-Rich Dietary Pattern. Nutrients, 11 (6), 1355. doi:
  2. Davis, J. M., Murphy, E. A., Carmichael, M. D. (2009). Effects of the Dietary Flavonoid Quercetin Upon Performance and Health. Current Sports Medicine Reports, 8 (4), 206–213. doi:
  3. Aguirre, L., Arias, N., Macarulla, M. T., Gracia, A., Portillo, M. P. (2011). Beneficial effects of quercetin on obesity and diabetes. The Open Nutraceuticals Journal, 4 (1), 189–198. doi:
  4. Tutel'ian, V. A., Lashneva, N. V. (2013). Biologically active substances of plant origin. Flavonols and flavones: prevalence, dietary sourses and consumption. Vopr Pitan, 82 (1), 4–22.
  5. Herrmann, K. (1976). Flavonols and flavones in food plants: a review. International Journal of Food Science & Technology, 11 (5), 433–448. doi:
  6. Moon, Y. J., Wang, L., DiCenzo, R., Morris, M. E. (2008). Quercetin pharmacokinetics in humans. Biopharmaceutics & Drug Disposition, 29 (4), 205–217. doi:
  7. Kleinedler, J. J., Foley, J. D., Alexander, J. S., Roerig, S. C., Hebert, V. Y., Dugas, T. R. (2011). Synergistic effect of resveratrol and quercetin released from drug-eluting polymer coatings for endovascular devices. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 99B (2), 266–275. doi:
  8. Tapsell, L. C., Neale, E. P., Probst, Y. (2019). Dietary Patterns and Cardiovascular Disease: Insights and Challenges for Considering Food Groups and Nutrient Sources. Current Atherosclerosis Reports, 21 (3). doi:
  9. Galkina, E., Ley, K. (2007). Vascular Adhesion Molecules in Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 27 (11), 2292–2301. doi:
  10. Maksiutina, N. P., Moibenko, A. A., Mokhart, N. A. et. al. (2012). Bioflavonoidy kak organoprotektory (kvercitin, korvitin, kvertin). Kyiv: Naukova dumka, 274.
  11. McKay, T. B., Karamichos, D. (2017). Quercetin and the ocular surface: What we know and where we are going. Experimental Biology and Medicine, 242 (6), 565–572. doi:
  12. Chirumbolo, S. (2010). The Role of Quercetin, Flavonols and Flavones in Modulating Inflammatory Cell Function. Inflammation & Allergy – Drug Targets, 9 (4), 263–285. doi:
  13. Li, Y., Yao, J., Han, C., Yang, J., Chaudhry, M., Wang, S. et. al. (2016). Quercetin, Inflammation and Immunity. Nutrients, 8 (3), 167. doi:
  14. Probst, Y., Guan, V., Kent, K. (2018). A systematic review of food composition tools used for determining dietary polyphenol intake in estimated intake studies. Food Chemistry, 238, 146–152. doi:
  15. Men, K., Duan, X., Wei, X., Gou, M., Huang, M., Chen, L. et. al. (2014). Nanoparticle-Delivered Quercetin for Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry, 14 (6), 826–832. doi:
  16. Andriichuk, Ya. R., Davtian, L. L. (2015). (2015). Investigation of antineoplastic activity of chewing tablets based on dry oat extract and quercetin. ScienceRise, 7 (1 (12)), 71–73. doi:
  17. Huang, R.-Y., Yu, Y.-L., Cheng, W.-C., OuYang, C.-N., Fu, E., Chu, C.-L. (2010). Immunosuppressive Effect of Quercetin on Dendritic Cell Activation and Function. The Journal of Immunology, 184 (12), 6815–6821. doi:
  18. Shi, Y., Su, X., Cui, H., Yu, L., Du, H., Han, Y. (2019). Combination of quercetin and Adriamycin effectively suppresses the growth of refractory acute leukemia. Oncology Letters, 18 (1), 153–160. doi:
  19. Lukiienko, O. V., Kvitchata, H. I., Oklei, D. V., Plys, S. V. (2014). Doslidzhennia vitchyznianoho rynku likarskykh zasobiv dlia mistsevoho zastosuvannia pry khronichnii venoznii nedostatnosti. Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky, 3 (16), 102–105.
  20. Davtian, L. L., Andriichuk, Ya. R. (2014). Problemni aspekty formuvannia asortymentu likarskykh zasobiv z adaptohennoiu ta zahalnotonizuiuchoiu aktyvnistiu v Ukraini. Farmatsevtychnyi zhurnal, 4, 73–76.
  21. Hodge, A., Bassett, J. (2016). What can we learn from dietary pattern analysis? Public Health Nutrition, 19 (2), 191–194. doi:
  22. Cespedes, E. M., Hu, F. B. (2015). Dietary patterns: from nutritional epidemiologic analysis to national guidelines. The American Journal of Clinical Nutrition, 101 (5), 899–900. doi:
  23. Rodríguez-Monforte, M., Flores-Mateo, G., Sánchez, E. (2015). Dietary patterns and CVD: a systematic review and meta-analysis of observational studies. British Journal of Nutrition, 114 (9), 1341–1359. doi:
  24. Terenda, N. O. (2015). Smertnist vid sertsevo-sudynnykh zakhvoriuvan yak derzhavna problema. Visnyk naukovykh doslidzhen, 4, 11–13.
  25. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017). Lancet, 390 (10100), 1211–1259. doi:
  26. Roth, G. A., Johnson, C., Abajobir, A., Abd-Allah, F. et. al. (2017). Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. Journal of the American College of Cardiology, 70 (1), 1–25.
  27. Rothwell, J. A., Knaze, V., Zamora-Ros, R. (2017). Polyphenols: dietary assessment and role in the prevention of cancers, 20 (6), 512–521.
  28. Ford, E. S., Capewell, S. (2011). Proportion of the Decline in Cardiovascular Mortality Disease due to Prevention Versus Treatment: Public Health Versus Clinical Care. Annual Review of Public Health, 32 (1), 5–22. doi:




How to Cite

Bobokalo, S., Almakaieva, L., Panfilova, H., & Tsurikova, O. (2019). Results of structural analysis of medical appointments of quercetin drugs and its derivatives in Ukraine. ScienceRise: Pharmaceutical Science, (6 (22), 30–37.



Pharmaceutical Science